Get started
Author

Traci M. Blonquist

Observed names: Blonquist, Traci, Blonquist, Traci M, Blonquist, Traci M., T. Blonquist, T.M. Blonquist, Traci Blonquist, Traci M Blonquist
Observed institutions: Boston Children's Hospital, Albert Einstein College of Medicine, Harvard University, University of Toronto, Wayne State University, Children's Hospital of Eastern Ontario, Hospital for Sick Children, St. Elizabeth's Medical Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, BioFortis (United States), University of Virginia, Seagen (United States)
ORCID: 0000-0003-1346-988X
Observed ORCID: 0000-0003-1346-988X
OpenAlex ID: A5071293141
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
2015 · Andrew E Place, Kristen E Stevenson, et al. · The Lancet Oncology · 248
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
2018 · Lynda M. Vrooman, Traci M. Blonquist, et al. · Blood Advances · 118
PDF
Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
2016 · Michael Xiang, Haesook Kim, et al. · Blood · 115
PDF
Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana‐Farber Cancer Institute ALL Consortium Protocols (2000–2010)
2016 · Kira Bona, Traci M. Blonquist, et al. · Pediatric Blood & Cancer · 115
Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis
2014 · Maryam Movassaghian, Andrew M. Brunner, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 101
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
2021 · Lynda M. Vrooman, Traci M. Blonquist, et al. · Journal of Clinical Oncology · 91
Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics
2015 · Donna Berry, Traci Blonquist, et al. · Patient Preference and Adherence · 82
PDF
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia
2015 · Peter D. Cole, Yaron Finkelstein, et al. · Journal of Clinical Oncology · 80
PDF
Exposure to a Patient-Centered, Web-Based Intervention for Managing Cancer Symptom and Quality of Life Issues: Impact on Symptom Distress
2015 · Donna L Berry, Traci M Blonquist, et al. · Journal of Medical Internet Research · 75
PDF
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes
2017 · Andrew M. Brunner, Traci M. Blonquist, et al. · Blood Advances · 66
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial
2017 · Donna L. Berry, Fangxin Hong, et al. · The Journal of Urology · 54
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia
2018 · Thai Hoa Tran, Marian H. Harris, et al. · Blood Advances · 49
Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia
2016 · Amir T. Fathi, Seth A. Wander, et al. · Haematologica · 46
PDF
Feasibility of Using Algorithm-Based Clinical Decision Support for Symptom Assessment and Management in Lung Cancer
2014 · Mary E. Cooley, Traci M. Blonquist, et al. · Journal of Pain and Symptom Management · 46
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia
2018 · M.L. Sulis, T.M. Blonquist, et al. · Pediatric Blood & Cancer · 40
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001
2017 · Justine M. Kahn, Peter D. Cole, et al. · Pediatric Blood & Cancer · 40
PDF
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
2021 · Yana Pikman, Sarah K. Tasian, et al. · Cancer Discovery · 39
PDF
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia
2018 · Marc R. Mansour, Shuning He, et al. · The Journal of Experimental Medicine · 34
PDF
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities
2018 · Olga K. Weinberg, Christopher J. Gibson, et al. · Haematologica · 34
Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis
2014 · Andrew M. Brunner, Traci M. Blonquist, et al. · Leukemia Research · 34
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation
2017 · Amir T. Fathi, Traci M. Blonquist, et al. · Cancer · 33
PDF
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial
2019 · Andrew M Brunner, Traci M Blonquist, et al. · The Lancet Haematology · 32
PDF
Psychosocial outcomes of an electronic self‐report assessment and self‐care intervention for patients with cancer: a randomized controlled trial
2016 · Jesse R. Fann, Fangxin Hong, et al. · Psycho-Oncology · 28
A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia
2019 · Rupa Narayan, Traci M. Blonquist, et al. · Cancer · 27
PDF
Patient-reported symptom distress, and most bothersome issues, before and during cancer treatment
2016 · Fangxin Hong, Traci Blonquist, et al. · Patient Related Outcome Measures · 27
PDF
Works count: 123
Citation count: 2,090
H-index: 26
I10-index: 44
Year
Topic
Type